BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 10867217)

  • 1. The role of cerebral ischemia in Alzheimer's disease.
    Kalaria RN
    Neurobiol Aging; 2000; 21(2):321-30. PubMed ID: 10867217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The blood-brain barrier and cerebrovascular pathology in Alzheimer's disease.
    Kalaria RN
    Ann N Y Acad Sci; 1999; 893():113-25. PubMed ID: 10672233
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vascular factors in Alzheimer's disease.
    Kalaria RN
    Int Psychogeriatr; 2003; 15 Suppl 1():47-52. PubMed ID: 16191216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alzheimer disease and cerebrovascular pathology: an update.
    Jellinger KA
    J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overlap between pathology of Alzheimer disease and vascular dementia.
    Kalaria RN; Ballard C
    Alzheimer Dis Assoc Disord; 1999; 13 Suppl 3():S115-23. PubMed ID: 10609690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small vessel disease and Alzheimer's dementia: pathological considerations.
    Kalaria RN
    Cerebrovasc Dis; 2002; 13 Suppl 2():48-52. PubMed ID: 11901243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Critically attained threshold of cerebral hypoperfusion: can it cause Alzheimer's disease?
    de la Torre JC
    Ann N Y Acad Sci; 2000 Apr; 903():424-36. PubMed ID: 10818533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of coincidental vascular pathology on symptomatology and course of Alzheimer's disease.
    Pasquier F; Leys D; Scheltens P
    J Neural Transm Suppl; 1998; 54():117-27. PubMed ID: 9850920
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular risk factors and Alzheimer's disease.
    Cechetto DF; Hachinski V; Whitehead SN
    Expert Rev Neurother; 2008 May; 8(5):743-50. PubMed ID: 18457531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
    Daulatzai MA
    J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of impaired cerebral circulation on Alzheimer's disease pathology: evidence from animal studies.
    Villarreal AE; Barron R; Rao KS; Britton GB
    J Alzheimers Dis; 2014; 42(3):707-22. PubMed ID: 24927711
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathological evaluation of mixed dementia.
    Jellinger KA; Attems J
    J Neurol Sci; 2007 Jun; 257(1-2):80-7. PubMed ID: 17324442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular risk factors in dementia.
    Schmidt R; Schmidt H; Fazekas F
    J Neurol; 2000 Feb; 247(2):81-7. PubMed ID: 10751108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between severe cerebral amyloid angiopathy and cerebrovascular lesions in Alzheimer disease is not a spurious one attributable to apolipoprotein E4.
    Olichney JM; Hansen LA; Hofstetter CR; Lee JH; Katzman R; Thal LJ
    Arch Neurol; 2000 Jun; 57(6):869-74. PubMed ID: 10867785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathology and pathophysiology of vascular cognitive impairment. A critical update.
    Jellinger KA
    Panminerva Med; 2004 Dec; 46(4):217-26. PubMed ID: 15876978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline.
    Wanleenuwat P; Iwanowski P; Kozubski W
    Postgrad Med; 2019 Sep; 131(7):415-422. PubMed ID: 31424301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of oxidative stress in the pathophysiology of cerebrovascular lesions in Alzheimer's disease.
    Aliev G; Smith MA; Seyidov D; Neal ML; Lamb BT; Nunomura A; Gasimov EK; Vinters HV; Perry G; LaManna JC; Friedland RP
    Brain Pathol; 2002 Jan; 12(1):21-35. PubMed ID: 11770899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired cerebromicrovascular perfusion. Summary of evidence in support of its causality in Alzheimer's disease.
    de la Torre JC
    Ann N Y Acad Sci; 2000; 924():136-52. PubMed ID: 11193790
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular basis of Alzheimer's pathogenesis.
    de la Torre JC
    Ann N Y Acad Sci; 2002 Nov; 977():196-215. PubMed ID: 12480752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
    Yew B; Nation DA;
    Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.